文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,550+ SCI 论文 与阿拉丁产品引用相关
2,304,480.59 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第3757至3768个,产品总数347,550个

切换升序
Advanced Healthcare Materials · 2026 · IF 11

Puerarin-Loaded Radially Aligned Tussah Silk/Chitosan/Graphene Oxide Nanofibrous Scaffolds for Enhanced Wound Healing

Yi Luo,Na Li,Shijun Lu,Yingchao Shen,Minxuan Han,Feng Zhang,Xue Wang

Wound healing remains a critical clinical challenge due to uncontrolled bleeding, bacterial infections, poor vascularization, and cell migration at damaged tissue sites. To address this challenge, we developed a radially structured, multifunctional biomimetic scaffold. Tussah silk was subjected to physical shearing and alkaline hydrolysis treatment to obtain tussah silk nanofibers (TSn). The TSn, chitosan (CS), and graphene oxide (GO) were then processed into radially aligned TSn/CS/GO scaffolds. These anisotropic composite scaffolds demonstrated not only antibacterial activity and rapid hemostatic properties but also effectively guided cell migration from the wound periphery toward the center. To achieve multifunctionality, including antioxidant activity, enhanced cell migration, and vascularization, the central void of the TSn/CS/GO scaffold was filled with a silk fibroin hydrogel integrated with Puerarin (PUE). In vivo studies using rat models confirmed that the TSn/CS/GO@PUE3 scaffold significantly accelerated wound healing (99.98 ± 0.02%), angiogenesis (the positive expression rates of CD31 and α-SMA were 21.66 ± 0.74% and 41.28 ± 1.09%, respectively), and collagen deposition (75.26 ± 2.10%). This study thus provides a valuable strategy for developing multifunctional biomimetic scaffolds to accelerate wound repair.

CAS / MDL: 1401-55-4
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ADVANCED MATERIALS · 2026 · IF 29.1

Fusion Peptide-Incorporated Lipid Nanoparticles Boost Endosomal Escape and Enhance Cytosolic mRNA Delivery

Yanan Meng,Yi Lin,Zijin Luo,Xiaoqiong Tan,Xiaolu Yu,Hongyu Ren,Qiang Cheng,Chuan Fang,Tuo Wei

The endosomal escape capability of current mRNA-loaded lipid nanoparticles (mRNA-LNPs) is generally low, which restricts their overall delivery efficiency. To address this limitation, we adopted a strategy inspired by the viral infection mechanism, utilizing fusion peptides to enhance the intracellular release of mRNA. Nine viral-derived and artificial fusion peptides were co-encapsulated within mRNA-LNPs respectively, termed FP-LNPs, and systematically assessed their efficacy in improving mRNA delivery. Notably, the HA2 fusion peptide from the influenza virus demonstrated a marked enhancement in mRNA delivery efficiency both in vitro and in vivo. Under acidic conditions of endosomes, HA2 collaborates with ionizable cationic lipids to facilitate endosomal membrane rupture, thereby promoting the release of mRNA into the cytoplasm and enhancing protein expression. Moreover, the incorporation of fusion peptides into various types of mRNA-LNP formulations significantly improved their in vivo delivery efficiency of mRNA, resulting in improved gene editing outcomes in the liver and lungs. Furthermore, in a Hereditary Tyrosinemia Type 1 (HT-1) mouse model, HA2-LNP significantly boosted FAH protein expression in the liver and more effectively prevented body weight loss and reduced liver fibrosis. Overall, this approach offers a promising strategy for enhancing endosomal escape and boosting the delivery efficiency of mRNA, underscoring its enhanced therapeutic potential.

CAS / MDL: 4004-05-1 70614-14-1
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Advanced Healthcare Materials · 2026 · IF 11

Microenvironment-Adaptive Smart Hydrogel with 2D Vanadium Nitride MXenzyme Rescues Osteoarthritis via Coordinated ROS Scavenging and Hspa5/GPX4 Axis-Mediated Ferroptosis Suppression

Yanlin Li,Xiaotian Jiang,Jiale Li,Hanwen Gu,Qi Li,Jiaxin Li,Yunqing Ji,Xiang Min,Bin Chen,Qingjia Xu,Junhao Lin

Osteoarthritis (OA), a prevalent degenerative joint disorder characterized by articular cartilage deterioration, represents a major global health challenge. Recent studies highlight the pivotal role of reactive oxygen species (ROS)-mediated ferroptosis in OA pathogenesis. Here, we report a microenvironment-adaptive hydrogel system based on 2D vanadium nitride (V 2 N) MXene nanoenzyme (hereafter denoted as V 2 N MXenzyme@Gel). This system features a dual-crosslinked network that optimally balances between mechanical robustness and flexibility. Crucially, the V 2 N MXenzyme establishes a self-sustaining “capture-conversion-recycling” catalytic cycle, mimicking both superoxide dismutase (SOD) and catalase (CAT) activities. The cycle not only neutralizes detrimental ROS into water (H 2 O) and oxygen (O 2 ) but also generates nitric oxide (NO), collectively alleviating oxidative damage. Mechanistically, V 2 N MXenzyme@Gel effectively scavenges ROS, attenuates oxidative stress, and suppresses ferroptosis by regulating the Hspa5/GPX4 axis, while concurrently restoring the metabolic homeostasis of chondrocyte extracellular matrix (ECM). Meanwhile, intra-articular administration of V 2 N MXenzyme@Gel significantly attenuates cartilage degradation and inflammation levels in OA rats. Collectively, our work presents a V 2 N MXenzyme@Gel with dual capabilities for ROS elimination and ferroptosis blockade, demonstrating its efficacy in arresting OA progression and proposing a novel precision strategy for managing chronic joint diseases.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Advanced Materials Technologies · 2026 · IF 6

Enhanced Liquid Metal-Hydrogel Interface for Fabricating a High-Precision Implantable Cardiac Pacemaker

Mingxi Tu,Chengzhi Zhang,Mingze Sun,Huan Wang,Bo Wang,Jiawen Liang,Yan Yang,Ying Zhao,Tianming Zhao,Haibo Yu

Implantable bioelectronic devices demonstrate immense potential in health monitoring and therapeutic interventions, yet encounter formidable challenges in achieving biocompatibility and interfacial stability within complex biological environments. This study proposes a novel liquid metal-hydrogel bonding strategy based on Cabrera–Mott oxidation kinetics regulation, which significantly enhances the printability of liquid metals on biocompatible hydrogel substrates through interfacial tension reduction and accelerated surface oxidation. Experimental findings revealed a 26.25% reduction in contact angle and a printing resolution improvement to 200 µm while maintaining superior electrical conductivity (3.83 × 10 5 S/m). Leveraging this advancement, we developed a flexible cardiac pacemaker integrating wireless energy transmission, pulse circuitry, and electrostimulation modules, which successfully achieved stable cardiac rhythm modulation in murine heart failure models. Histopathological analyses further corroborated the device's biosafety profile. This study presents a promising strategy for miniaturized implantable bioelectronics design and biointerface optimization, offering valuable insights for the development of future personalized bioelectronic systems.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
Small · 2026 · IF 11.8

Macrophage Phenotype–Dependent Protein Corona Formation Governs Ligand Accessibility and Immune Clearance of Biomimetic Nanoparticles

Tianchang He,Lina Zhu,Jiayi Ding,Xiaoyan Fang,Yu Gao,Volker Mailänder,Daniel Crespy,Katharina Landfester,Shuai Jiang

The phenotype of source cells used for membrane coating fundamentally influences the biointerfacing behavior of cell membrane-coated nanoparticles. Meanwhile, the formation of a protein corona (PC) in biological fluids plays a pivotal role in dictating the in vivo fate of nanoparticles. Yet, how macrophage phenotypes influence PC composition and, in turn, dictate the clearance of biomimetic nanoparticles remains underexplored. Here, we prepared magnetic silica nanoparticles (SMNs) coated with membranes from M0, M1, and M2 macrophages (denoted as M0@SMNs, M1@SMNs, and M2@SMNs) to elucidate phenotype-dependent PC fingerprints and their impact on immune recognition and clearance. In vivo and in vitro studies demonstrated that M0@SMNs exhibited superior immune evasion, reduced hepatic clearance, and prolonged blood retention. Nano-flow cytometry revealed that PC formation masked up to ≈40% of surface membrane proteins. Furthermore, proteomics, Western blotting, and ELISA analyses confirmed that M0@SMNs exhibited minimal adsorption of immune opsonins (C3, IgG, IgM) and triggered the lowest complement activation, which account for their attenuated hepatic clearance. Collectively, these findings identify source cell phenotype as a key determinant of PC composition and clearance fate, thereby offering mechanistic guidance for the rational design of biomimetic nanocarriers. Notably, M0 macrophages confer superior systemic circulation relative to M1 and M2 counterparts.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Journal of the American Chemical Society · 2026 · IF 16.6

FAP-Synergistic Organ-Targeted mRNA-LNP for Overcoming Delivery Barriers in Hepatic and Pulmonary Fibrosis

Chenlong Wei,Xinzhu Shan,Yuxuan Huang,Bin Ma,Zhiqiang Zhao,Yian Fang,Chengrui Bai,Zihan Zhang,Peng Zhao,Huijuan Zhang,Yu Hou,Tianjiao Ji,Zhongtang Li,Song Song,Fei Xie,Lei Miao

The inefficient delivery of lipid nanoparticles (LNPs)-encapsulated mRNA to activated fibroblasts in fibrotic tissues remains a major challenge for antifibrotic therapy. To overcome this, we develop a fibrosis organ and cell unified-targeting system (FOCUS) for mRNA delivery with LNPs. FOCUS LNPs combines an ionizable lipid library (synthesized via Ugi multicomponent reactions) with fibroblast activation protein-α (FAP)-targeting lipid-like ligands. These LNPs achieve ∼3-fold and ∼12-fold greater mRNA expression in fibrotic liver and lung, along with ∼2–5-fold higher fibroblast distribution─unattainable by organ- or ligand-only targeting. As proof of concept, Pentraxin-2 mRNA (mPTX-2)-loaded FOCUS LNPs drive localized PTX-2 production in murine models of pulmonary and hepatic fibrosis, reducing collagen deposition by 60–80% while avoiding systemic side effects like impaired wound healing. Mechanistically, mPTX-2 FOCUS LNPs suppress monocyte-to-fibrocyte differentiation, M2 macrophage polarization, and fibroblast activation. This work establishes a precision mRNA delivery platform for fibrotic diseases, offering a safer and more effective therapeutic strategy.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY · 2026 · IF 6.7

BarH1 and BarH2 Regulate the Expression of Odorant-Binding Protein 4 to Mediate the Recognition of Two Volatiles in Dastarcus helophoroides

Rui-Lin Zhang,Jia-Qing Wang,Sara Taha Abdelkhalek,Shan-Cheng Yi,Yuping Zha,Man-Qun Wang

The olfactory system is pivotal for insect behavior, with odorant-binding proteins (OBPs) serving as primary detectors for semiochemicals. Previous studies demonstrated that DhelOBP4 in Dastarcus helophoroides is essential for detecting herbivore-induced plant volatiles (HIPVs). Here, we demonstrated through dual-luciferase reporter assays, yeast one-hybrid (Y1H) assays, and electrophoretic mobility shift assays (EMSA) that transcription factors BarH1/2 directly activate DhelOBP4 expression by binding to its promoter. RNAi knockdown revealed sex-specific regulation: BarH1 silencing significantly reduced DhelOBP4 expression only in females, whereas BarH2 knockdown affected both sexes. Y-tube olfactometer assays showed that BarH1 depletion abolished female attraction to α-pinene and 2-undecyloxy-1-ethanol, as well as male attraction to α-pinene. BarH2 knockdown eliminated attraction in both sexes and reversed the female response to α-pinene from attraction to repulsion. These findings establish DhelOBP4 as a key detector of these volatiles, under sex-specific regulation by BarH1/2 to modulate behavior, revealing novel mechanisms in tritrophic interactions.

CAS / MDL: 67-56-1
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Applied Nano Materials · 2026 · IF 5.8

RVG29-Decorated PLGA/Piperine Nanoparticles for Treating Parkinson’s Disease via Restoring Neuronal Energy Metabolism

Chunlian Liu,Siwen Wang,Haifan Yu,Kai Duo,Chunyu Wang,Jing Jiang,Lin Li

Parkinson’s disease (PD), the second leading cause of neurodegenerative disease worldwide, severely impairs the quality of life for the elderly. While current clinical treatments can alleviate symptoms, they fail to halt the progressive death of neurons, making the disease progression irreversible. This treatment bottleneck is largely attributed to the inability to effectively alleviate the “energy metabolism crisis” of dopaminergic neurons. Against this backdrop, piperine (Pip) has shown some neuroprotective potential, but its poor water solubility and inability to penetrate the blood–brain barrier (BBB) limit its application. This study aimed to develop RVG29 peptide-modified erythrocyte membrane biomimetic nanoparticles (RVG29-RM@Pip NPs) to address delivery challenges and explore metabolic intervention strategies. This system uses PLGA to load piperine, achieving immune escape and active brain targeting through biomimetic camouflage and RVG29 guidance. In vitro and in vivo experiments confirmed that these nanoparticles can efficiently penetrate the BBB, restore mitochondrial membrane potential, scavenge reactive oxygen species, and significantly improve motor dysfunction and neuronal loss in MPTP mice. Mechanistically, it remodels neuronal glycolysis and respiratory chain function by synergistically upregulating GLUT1, the rate-limiting enzyme PGK1, and mitochondrial complex I, restoring energy homeostasis and inhibiting apoptosis. This study not only constructed a brain-targeted delivery system but also revealed a mechanism and candidate approach for treating PD through metabolic remodeling.

✓ 已验证 产品关联 DOI 高影响因子
查看原文 查看 PubMed
MOLECULAR PHARMACEUTICS · 2026 · IF 4.9

Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy

Fangzhou Yang,Yunqian Lu,Xiaoxue Lang,Lina Sun,Hang Zou,Ziting Zhou,Yaoyao Guo,Yifei Guo,Xiangtao Wang,Meihua Han

Whole cells serve as promising carriers for delivering bioactive molecules owing to their superior biocompatibility, minimal immunogenicity, and extended circulation time. In addition to preserving the intact cellular structure and functions, they provide abundant tumor-associated antigens as immune targets, providing a basis for tumor vaccine development. However, conventional chemotherapy with doxorubicin (DOX) suffers from limited tumor-targeting ability and severe systemic toxicity, which markedly restrict its therapeutic efficacy. In this study, we establish a simple liquid nitrogen freezing strategy to load DOX into liquid-nitrogen-treated (LNT) tumor cells for homologous targeting of breast cancer. The optimized formulation achieved a DOX loading of 38.28 ± 1.61 μg/5 × 106 cells. Both in vitro and in vivo studies confirm that the prepared DOX/LNT cell formulation exhibits excellent safety with no proliferative or pathogenic potential. Regarding the antitumor effect of DOX/LNT cells, in vitro cytotoxicity assays reveal an IC50 value of 1.104 μg/mL, representing a 1.87-fold improvement over free DOX. Furthermore, DOX/LNT cell achieves superior antitumor efficacy by combining chemotherapy with the activation of antitumor immune responses. Following intravenous administration via tail vein injection, in vivo studies demonstrated a tumor inhibition rate of 81.81%, extending the average survival time of breast tumor-bearing mice to 56 days. This approach offers a novel drug delivery system with improved tumor-targeting specificity, representing a precise and effective therapeutic strategy that integrates chemotherapy and immunotherapy for breast cancer treatment.

CAS / MDL: 115144-35-9
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ACS Biomaterials Science & Engineering · 2026 · IF 6

Silk Fibroin Biomimetic Membranes with Villus–Crypt Architecture for In Vitro Intestinal Epithelium Modeling

Lei Liu,Ziqing Zhu,Lunxiang Chen,Xuan Lv,Yixin Jiao,Yifan Zhang,Xiuli Wang,Antonella Motta,Xiaoqin Wang

Three-dimensional (3D) intestinal models require physiologically relevant microarchitectures and mechanically supportive matrices to accurately replicate epithelial behavior; however, most existing in vitro systems lack villus–crypt topography and do not provide the material cues needed to guide epithelial organization. In this work, we developed biomimetic silk fibroin (SF) membranes that reproduce the native villus–crypt structure using two complementary cross-linking and processing strategies: chemical cross-linking with BDDE to form soft hydrogels and ethanol-induced β-sheet formation to generate stiff, dimensionally stable membranes. These routes were selected because they produce distinct material classes with nonoverlapping ranges of crystallinity, hydrophilicity, and stiffness, enabling access to mechanical regimes unattainable through a single cross-linking method. Villus–crypt architectures were replicated with high fidelity using customized molds. By culturing Caco-2 cells on these patterned SF membranes, we systematically examined how matrix stiffness and β-sheet content influence epithelial adhesion, proliferation, and differentiation. The physically cross-linked membranes (∼20 MPa) supported robust spreading, confluent monolayer formation, and relatively high ALP activity, whereas the softer hydrogels (∼15 kPa) limited adhesion and proliferation. Collectively, this study establishes a tunable SF-based platform that provides both physiological topography and mechanical support, offering a promising foundation for advanced 3D in vitro intestinal epithelial models.

CAS / MDL: 7550-35-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
EBioMedicine · 2026 · IF 11.2

Effects of gestational perfluorohexanesulfonic acid exposure at human realistic dose on social communication deficit in mouse offspring

Shengmei Zhang,Chang Gao,Ruonan Li,Jia Lv,Jingjing Xu,Maohua Miao,Hong Liang,De-Xiang Xu,Bo Wang,Yichao Huang

Background Early-life exposure to exogenous chemicals can disrupt neurodevelopment. Perfluorohexanesulfonic acid (PFHxS), a legacy PFAS widely used and detected globally, remains poorly studied for its neurotoxicity. Methods CD-1 mice (n = 90 dams) were exposed to human-relevant dose of PFHxS from gestational day (GD) 0–17. PFHxS levels were measured in maternal plasma and foetal/offspring medial prefrontal cortex (mPFC) (GD 18, postnatal weeks [PNW] 4 and 10) using liquid chromatography tandem mass-spectrometry (LC-MS/MS). Offspring social behaviour was assessed with the Three-Chamber social test. Neurotransmitters in mPFC of PNW 10 offspring were profiled by LC-MS/MS, transcriptomics was performed on GD 18 and PNW 4 mPFC, GABAergic neurons were quantified by immunofluorescence, and glutamate decarboxylase (GAD) expression by western blotting. PFHxS-GAD interactions were examined via molecular docking and microscale thermophoresis (MST). Findings Maternal plasma reached 5.1 ± 0.1 ng/mL, equivalent to human biomonitoring data, and PFHxS accumulated in foetal mPFC (68.1 ± 4.1 pg/g). PFHxS exposure induced social deficits at PNW 4 and 10, which were more pronounced in males. The mPFC of PFHxS exposed offspring exhibited an excitatory-tilted neurotransmitter profile, feature with reduced γ-aminobutyric acid (GABA, 90.6 ± 12.2 vs. 70.2 ± 4.3 μg/g, p = 0.008). The differentially expressed genes were enriched in GABAergic and synaptic signalling pathways. Despite unchanged percentage of GABAergic neuron and GAD expression, metabolite GABA/glutamate ratio was attenuated, suggesting impaired GAD function. Both molecular docking and MST suggested moderate-to-strong binding affinity between PFHxS and GAD, affecting GABA synthesis. Interpretation Gestational PFHxS exposure at human-relevant levels impairs offspring social behaviour, likely via disruption of GAD-mediated imbalance in excitation/inhibition. Funding This work was provided by grants from the National Natural Science Foundation of China (82404221 and 82373586), Anhui Provincial Natural Science Foundation (2308085Y50 and 2408085QH275), Education Department of Anhui Province for Excellent Young Scientist (2022AH030076), and funding from Center for Big Data and Population Health of IHM (JKS2022020).

CAS / MDL: 8001-30-7
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Cell Reports Medicine · 2026 ·Vol. 7 ·期 2 · IF 14

A human patient-derived organoid biobank to model tumor heterogeneity and therapeutic vulnerability for oral squamous cell carcinoma

Yuhan Wang,Pengfei Diao,Pin Lv,Na Qi,Ziyu Wang,Enshi Yan,Jin Li,Yanling Wang,Dongmiao Wang,Yaping Wu,Jie Cheng

Oral squamous cell carcinoma (OSCC) remains a significant clinical challenge due to frequent recurrence, metastasis, and therapeutic resistance. Here, we establish a living biobank of OSCC patient-derived organoids (PDOs) comprising 46 lines using optimized culture medium. These PDOs are long-term passaged, cryopreserved, and recovered with stable viability and tumorigenicity. Comprehensive morphological, genomic, and transcriptomic analyses confirm that PDOs faithfully recapitulate the histopathological, genetic, and molecular features of parental tumors. These PDOs enable disease modeling, genetic manipulation, and drug screening. Through transcriptomic profiling and functional assays, we find that CDCP1 mediates cisplatin resistance by modulating Wnt/β-catenin signaling-driven stemness. Notably, we develop a pH-sensitive nanoparticle delivering siCDCP1, which effectively restores chemosensitivity and impairs tumor growth in cisplatin-resistant patient-derived xenograft (PDX) models with favorable safety profile. These findings establish PDOs as robust preclinical models for mechanistic explorations and therapeutics development and highlight CDCP1-targeting strategies as promising approaches to overcome cisplatin resistance in OSCC.

CAS / MDL: 9003-98-9
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。